Xiaochang Xue Selected Research

Xiaochang Xue Research Topics

Disease

19	Neoplasms (Cancer) 04/2022 - 07/2007
5	Neoplasm Metastasis (Metastasis) 01/2017 - 02/2008
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2019 - 09/2013
4	Carcinoma (Carcinomatosis) 01/2018 - 07/2007
4	Rheumatoid Arthritis 01/2018 - 01/2009
3	Breast Neoplasms (Breast Cancer) 01/2018 - 09/2015
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2018 - 12/2011
3	Body Weight (Weight, Body) 04/2016 - 02/2016
2	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 01/2018
2	Insulin Resistance 10/2021 - 12/2020
2	Autoimmune Diseases (Autoimmune Disease) 01/2018 - 06/2008
2	Osteoarthritis 01/2016 - 09/2014
2	Inflammation (Inflammations) 01/2016 - 07/2014
2	Wounds and Injuries (Trauma) 05/2015 - 01/2015
2	HIV Infections (HIV Infection) 06/2013 - 09/2006
1	Osteosarcoma (Osteogenic Sarcoma) 04/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Non-alcoholic Fatty Liver Disease 01/2021
1	Diabetes Mellitus 12/2020
1	Hyperglycemia 12/2020
1	Hyperlipidemias (Hyperlipidemia) 12/2020
1	Hypoxia (Hypoxemia) 11/2019
1	Glioma (Gliomas) 01/2018
1	Lung Neoplasms (Lung Cancer) 01/2018
1	Short Bowel Syndrome 01/2017
1	Pelvic Neoplasms 01/2017
1	Necrosis 11/2015
1	Corneal Injuries 05/2015
1	Stomach Ulcer (Gastric Ulcer) 05/2015
1	Chemical Burns (Chemical Burn) 01/2015
1	Burns 01/2015
1	Hyperplasia 09/2014
1	Experimental Arthritis 09/2014
1	Arthritis (Polyarthritis) 09/2014

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2007
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 04/2007
4	MicroRNAs (MicroRNA)IBA 01/2016 - 12/2011
3	Therapeutic UsesIBA 01/2021 - 04/2007
3	AutovaccinesIBA 01/2009 - 04/2007
2	Messenger RNA (mRNA)IBA 11/2019 - 03/2016
2	Transcription Factors (Transcription Factor)IBA 11/2019 - 07/2017
2	DNA (Deoxyribonucleic Acid)IBA 11/2019 - 01/2018
2	VaccinesIBA 01/2018 - 06/2008
2	CytokinesIBA 01/2018 - 01/2016
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2015 - 09/2013
2	Monoclonal AntibodiesIBA 11/2015 - 09/2013
2	Small Interfering RNA (siRNA)IBA 09/2015 - 09/2014
2	Biological ProductsIBA 09/2015 - 03/2010
1	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2022
1	Glycoside Hydrolase InhibitorsIBA 10/2021
1	IridoidsIBA 01/2021
1	GlycosidesIBA 01/2021
1	Streptozocin (Streptozotocin)FDA Link 01/2021
1	SugarsIBA 01/2021
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 12/2020
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 12/2020
1	Glucose (Dextrose)FDA LinkGeneric 12/2020
1	AcidsIBA 12/2020
1	Hypoglycemic Agents (Hypoglycemics)IBA 12/2020
1	Sterol Regulatory Element Binding Protein 1IBA 12/2020
1	TriterpenesIBA 12/2020
1	AMP-Activated Protein KinasesIBA 12/2020
1	Erythropoietin Receptors (Erythropoietin Receptor)IBA 11/2019
1	ChromatinIBA 11/2019
1	Erythropoietin FDA Link 11/2019
1	Matrix Metalloproteinase 7 (Matrilysin)IBA 01/2018
1	LigandsIBA 01/2018
1	1-nitrohydroxyphenyl-N-benzoylalanine (GAL 1)IBA 01/2018
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2018
1	Glucagon (Glukagon)FDA Link 01/2018
1	angiotensin I (1-7)IBA 01/2018
1	human ERBB2 proteinIBA 01/2018
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2017
1	Glucagon-Like Peptide 2IBA 01/2017
1	VinculinIBA 01/2017
1	YY1 Transcription FactorIBA 01/2016
1	Infliximab (Remicade)FDA Link 11/2015
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 09/2015
1	Epidermal Growth Factor (EGF)IBA 05/2015
1	Cisplatin (Platino)FDA LinkGeneric 04/2015
1	Carboplatin (JM8)FDA LinkGeneric 04/2015
1	Docetaxel (Taxotere)FDA Link 04/2015
1	BPC 157IBA 01/2015
1	Indicators and Reagents (Reagents)IBA 01/2015
1	AlkaliesIBA 01/2015
1	Discoidin Domain Receptor 2IBA 09/2014
1	Hematoxylin (Haematoxylon)IBA 09/2014
1	Eosine Yellowish-(YS) (Eosin)IBA 09/2014
1	Annexin A2 (Annexin II)IBA 09/2014
1	Matrix Metalloproteinases (MMPs)IBA 09/2014
1	Matrix Metalloproteinase 13IBA 09/2014
1	Interleukin-10 (Interleukin 10)IBA 07/2014
1	Interleukin-27 (Interleukin 27)IBA 07/2014
1	LuciferasesIBA 03/2014
1	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 01/2014

Therapy/Procedure

7	Therapeutics 01/2022 - 02/2008
4	Drug Therapy (Chemotherapy) 04/2022 - 02/2012
3	Immunotherapy 01/2018 - 01/2007
2	Radiotherapy 01/2017 - 07/2013
2	Intraperitoneal Injections 04/2016 - 02/2016